← Leaderboards
Lance A Liotta
Clinical Sciences
$8,006,566
Attributed
$8,734,235
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–20$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,734,235 · 13
By mechanism
R21$3,761,271 · 9
R33$3,240,236 · 3
R01$1,732,728 · 1
Top collaborators
- Virginia Anne Espina4 shared
- Serguei Popov3 shared
- Kathleen M Mulder2 shared
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyProteinsAffinityChemistryPeptidesNew TechnologyBaseMolecularHuman TissueSignal TransductionValidationOne-Step Dentin Bonding SystemMalignant NeoplasmsComplexPeptide HydrolasesCollectionMass Spectrum AnalysisProteomicsBiological PreservationNanoparticleSamplingNext GenerationMeasurementHydrogels
Grant awards (62)
Bridging adult to pediatric markers of tuberculosis disease severity$220,976
R21 · FY2020 · HD · contact PI
Bridging adult to pediatric markers of tuberculosis disease severity$205,289
R21 · FY2019 · HD · contact PI
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease$191,365
R21 · FY2019 · AG
Protein painting identifies therapeutic targets at protein-protein interfaces$348,203
R33 · FY2018 · CA · contact PI
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease$243,015
R21 · FY2018 · AG
Protein painting identifies therapeutic targets at protein-protein interfaces$94,518
R33 · FY2018 · CA · contact PI
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation$568,784
R01 · FY2017 · AR · contact PI
Protein painting identifies therapeutic targets at protein-protein interfaces$348,203
R33 · FY2017 · CA · contact PI
Protein painting identifies therapeutic targets at protein-protein interfaces$94,518
R33 · FY2017 · CA · contact PI
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation$568,784
R01 · FY2016 · AR · contact PI
Protein painting identifies therapeutic targets at protein-protein interfaces$348,203
R33 · FY2016 · CA · contact PI
Microparticles for Directing Immune Cell Trafficking$228,000
R21 · FY2016 · AI · contact PI
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation$595,160
R01 · FY2015 · AR · contact PI
Microparticles for Directing Immune Cell Trafficking$189,781
R21 · FY2015 · AI
Nanotrap technology for one step preservation and amplification of cancer biomark$357,556
R33 · FY2014 · CA · contact PI
Protein Painting reveals hidden protein-protein interaction domains$237,319
R21 · FY2014 · CA · contact PI
Microparticle Capture-Based Analysis of Lymph Node Proteome$220,875
R21 · FY2014 · AI
Nanotrap technology for one step preservation and amplification of cancer biomark$346,498
R33 · FY2013 · CA · contact PI
Implementation of phosphoprotein preservation technology for cancer biospecimens$285,213
R33 · FY2013 · CA · contact PI
Protein Painting reveals hidden protein-protein interaction domains$244,659
R21 · FY2013 · CA · contact PI
Microparticle Capture-Based Analysis of Lymph Node Proteome$184,063
R21 · FY2013 · AI
Nanotrap technology for one step preservation and amplification of cancer biomark$380,428
R33 · FY2012 · CA · contact PI
Implementation of phosphoprotein preservation technology for cancer biospecimens$309,458
R33 · FY2012 · CA · contact PI
A non-invasive nanotechnology-based skin patch for multiplexed diagnostics$196,425
R21 · FY2012 · AR · contact PI
Implementation of phosphoprotein preservation technology for cancer biospecimens$327,438
R33 · FY2011 · CA · contact PI
A non-invasive nanotechnology-based skin patch for multiplexed diagnostics$163,688
R21 · FY2011 · AR · contact PI
Nanotechnology for One Step Concentration and Preservation of Labile Biomarkers i$179,916
R21 · FY2010 · CA · contact PI
Nanotechnology for One Step Concentration and Preservation of Labile Biomarkers i$200,433
R21 · FY2009 · CA · contact PI
Phosphorylated signal pathway proteins: A new class of vitreous biomarkers for op$192,775
R21 · FY2009 · EY · contact PI
Nanotechnology for One Step Concentration and Preservation of Labile Biomarkers i$149,220
R21 · FY2009 · CA · contact PI
Surrogate and Sentinal Technologies to Monitor Stability of Cancer Phosphoprotein$139,874
R21 · FY2009 · CA · contact PI
Surrogate and Sentinal Technologies to Monitor Stability of Cancer Phosphoprotein$10,805
R21 · FY2009 · CA · contact PI
Phosphorylated signal pathway proteins: A new class of vitreous biomarkers for op$10,649
R21 · FY2009 · EY · contact PI
Surrogate and Sentinal Technologies to Monitor Stability of Cancer Phosphoprotein$179,404
R21 · FY2008 · CA · contact PI
Phosphorylated signal pathway proteins: A new class of vitreous biomarkers for op$172,740
R21 · FY2008 · EY · contact PI
Stimulated Motility in Tumor Cells$0
Z01 · FY2005 · SC
Stimulated Motility in Tumor Cells$0
Z01 · FY2004 · SC
Drosophila Model for the Identification of Proteins Invo$0
Z01 · FY2004 · SC
Postmortem Pathology$0
Z01 · FY2004 · SC
Laser Capture Microdissection and Clinical Proteomics$0
Z01 · FY2004 · SC
Cytology Applied to Human Diagnostic Problems and Resear$0
Z01 · FY2004 · SC
Laser Capture Microdissection and Clinical Proteomics$0
Z01 · FY2003 · SC
Drosophila Model for the Identification of Proteins Invo$0
Z01 · FY2003 · SC
Postmortem Pathology$0
Z01 · FY2003 · SC
Postmortem Pathology$0
Z01 · FY2003 · SC
Stimulated Motility in Tumor Cells$0
Z01 · FY2003 · SC
Cytology Applied to Human Diagnostic Problems and Resear$0
Z01 · FY2003 · SC
Cytology Applied to Human Diagnostic Problems and Resear$0
Z01 · FY2002 · SC
Drosophila Model for the Identification of Proteins Invo$0
Z01 · FY2002 · SC
Postmortem Pathology$0
Z01 · FY2002 · SC
Laser Capture Microdissection applied to human pathophys$0
Z01 · FY2002 · SC
Stimulated Motility in Tumor Cells$0
Z01 · FY2002 · SC
Stimulated Motility in Tumor Cells$0
Z01 · FY2001 · SC
Drosophila Model for the Identification of Proteins$0
Z01 · FY2001 · SC
Postmortem Pathology$0
Z01 · FY2001 · SC
Laser Capture Microdissection in Human Pathophysiology$0
Z01 · FY2001 · SC
Cytology Applied to Human Diagnostic Problems$0
Z01 · FY2001 · SC
Laser Capture Microdissection applied to human pathophysiology$0
Z01 · FY2000 · SC
Drosophila Model for the Identification of Proteins Involved in Tumor Cell Motil$0
Z01 · FY2000 · SC
Postmortem Pathology$0
Z01 · FY2000 · SC
Cytology Applied to Human Diagnostic Problems and Research Problems$0
Z01 · FY2000 · SC
Stimulated Motility in Tumor Cells$0
Z01 · FY2000 · SC